| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $825.7M | $836.3M | $813.1M |
| YoY Revenue Growth % | -1.3% | +2.9% | — |
| Gross Profit | $276.1M | $270.8M | — |
| Gross Margin % | 33.4% | 32.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $74.6M | $44.5M | $72.4M |
| Operating Margin % | 9.0% | 5.3% | 8.9% |
| Net Income (GAAP) | $34.9M | $7.2M | $48.9M |
| EBITDA (Normalized) | $90.2M | $64.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $86.8M | $79.3M | $86.2M |
| Capital Expenditures (CapEx) | $19.6M | $24.4M | — |
| Free Cash Flow (FCF) | $67.2M | $54.9M | $86.2M |
| FCF Margin % | 8.1% | 6.6% | 10.6% |
| Return on Invested Capital (ROIC %) | 10.4% | 5.9% | — |
| Cash & Short-Term Equivalents | $40.5M | $32.2M | — |
| Total Debt (Short + Long Term) | $311.2M | $355.3M | — |
| Total Stockholders' Equity | $294.2M | $277.5M | — |